Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 40

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 40
---
ata Pharmaceuticals, Inc.’s ability to continue as a going concern as described
in Note 2 to the consolidated financial statements) which is incorporated by reference in this prospectus and elsewhere in the registration
statement. Our consolidated financial statements are incorporated by reference in reliance on Ernst & Young LLP’s report,
given on their authority as experts in accounting and auditing.

<div align='center'>29

WHERE YOU CAN FIND MORE INFORMATION</div>

We have filed with the SEC
a registration statement on Form S-3 under the Securities Act, with respect to the securities being offered by this prospectus. This
prospectus does not contain all of the information in the registration statement and its exhibits. For further information with respect
to us and the securities offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained
in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance,
we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements
is qualified in all respects by this reference. The SEC maintains a website that contains reports, proxy statements, and other information
about registrants, like us, that file electronically with the SEC. The address of that website is . The information
contained in, or that can be accessed through, the SEC’s website is not incorporated by reference in, and is not part of, this prospectus
or any prospectus supplement.

We are subject to the information
and periodic reporting requirements of the Exchange Act, and we file periodic reports, proxy statements and other information with the
SEC. We maintain a website at https://www.armatapharma.com/. You may access our annual reports on Form 10-K, quarterly reports on
Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or
15(d) of the Exchange Act with the SEC free of charge at our website as soon as reasonably practicable after such material is electronically
filed with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not incorporated by
reference in, and is not part of, this prospectus.

<div align='center'>30

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC allows us to “incorporate
by reference” information that we file with it